Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taurolock-hep500 vs Heparin for Hemodialysis Catheters
NCT03539718Phase 4Unknown
- Sponsor
- Ain Shams University
- Start
- May 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of TauroLock-Hep500 in catheter-related bloodstream infection (CRBSI), catheter-related thrombosis (CRT), sponsored by Ain Shams University. Status: unknown.
02
Drugs
TauroLock-Hep500
03
Conditions
catheter-related bloodstream infection (CRBSI)catheter-related thrombosis (CRT)
Beyond the preview
Go deeper on NCT03539718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03539718.